Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)
|
February 27, 2024
[Current therapeutic standards in advanced soft tissue sarcomas]
Anton Burkhard-Meier, Luc M Berclaz, Dorit Di Gioia, et al.
Life (Basel, Switzerland)
|
September 23, 2020
The Impact of a Nanocellulose-Based Wound Dressing in the Management of Thermal Injuries in Children: Results of a Retrospective Evaluation
Julia Cattelaens, Laura Turco, Luc M Berclaz, et al.
Annals of Surgical Oncology
|
November 21, 2024
Preoperative Radiation Therapy is Not Associated with Postoperative Complications in Patients with Retroperitoneal Sarcoma
Luc M Berclaz, Saveli I Goldberg, Sonia Cohen, et al.
Frontiers in Oncology
|
November 4, 2024
Surgical site infections after sarcoma resections in the peripelvic region: do we need perioperative antibiotic prophylaxis?
Alexander Klein, Chataut Chudamani, Andreas Wieser, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
September 18, 2024
Advancements in opportunistic intracranial aneurysm screening: The impact of a deep learning algorithm on radiologists' analysis of T2-weighted cranial MRI
Bianca Teodorescu, Leonard Gilberg, Ali Murat Koç, et al.
Cancers
|
October 13, 2021
Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy
Luc M Berclaz, Annelore Altendorf-Hofmann, Hans Roland Dürr, et al.
Cancers
|
June 22, 2023
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)
Luc M Berclaz, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Journal of Cancer Research and Clinical Oncology
|
August 5, 2023
Implementing precision oncology for sarcoma patients: the CCC<sup>LMU</sup>molecular tumor board experience
Luc M Berclaz, Anton Burkhard-Meier, Philipp Lange, et al.
BMC Cancer
|
April 11, 2025
The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcoma
Luc M Berclaz, Dorit Di Gioia, Michael Völkl, et al.
BMC Cancer
|
March 19, 2025
LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatment
Luc M Berclaz, Dorit Di Gioia, Vindi Jurinovic, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Deutsche Medizinische Wochenschrift (1946)
|
February 27, 2024
[Current therapeutic standards in advanced soft tissue sarcomas]
Anton Burkhard-Meier, Luc M Berclaz, Dorit Di Gioia, et al.
Life (Basel, Switzerland)
|
September 23, 2020
The Impact of a Nanocellulose-Based Wound Dressing in the Management of Thermal Injuries in Children: Results of a Retrospective Evaluation
Julia Cattelaens, Laura Turco, Luc M Berclaz, et al.
Annals of Surgical Oncology
|
November 21, 2024
Preoperative Radiation Therapy is Not Associated with Postoperative Complications in Patients with Retroperitoneal Sarcoma
Luc M Berclaz, Saveli I Goldberg, Sonia Cohen, et al.
Frontiers in Oncology
|
November 4, 2024
Surgical site infections after sarcoma resections in the peripelvic region: do we need perioperative antibiotic prophylaxis?
Alexander Klein, Chataut Chudamani, Andreas Wieser, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
September 18, 2024
Advancements in opportunistic intracranial aneurysm screening: The impact of a deep learning algorithm on radiologists' analysis of T2-weighted cranial MRI
Bianca Teodorescu, Leonard Gilberg, Ali Murat Koç, et al.
Cancers
|
October 13, 2021
Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy
Luc M Berclaz, Annelore Altendorf-Hofmann, Hans Roland Dürr, et al.
Cancers
|
June 22, 2023
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)
Luc M Berclaz, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Journal of Cancer Research and Clinical Oncology
|
August 5, 2023
Implementing precision oncology for sarcoma patients: the CCC<sup>LMU</sup>molecular tumor board experience
Luc M Berclaz, Anton Burkhard-Meier, Philipp Lange, et al.
BMC Cancer
|
April 11, 2025
The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcoma
Luc M Berclaz, Dorit Di Gioia, Michael Völkl, et al.
BMC Cancer
|
March 19, 2025
LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatment
Luc M Berclaz, Dorit Di Gioia, Vindi Jurinovic, et al.
Page
of 2